Murakami H - Search Results

1

Primary nonsecretory plasma cell leukemia: a rare variant of multiple myeloma.

Kawada E, Shinonome S, Saitoh T, Tamura J, Karasawa M, Sawamura M, Murakami H. Kawada E, et al. Among authors: murakami h. Ann Hematol. 1999 Jan;78(1):25-7. doi: 10.1007/s002770050467. Ann Hematol. 1999. PMID: 10037265

2

A patient with primary plasma cell leukemia accompanied by an extensive polypoid infiltration of the gastrointestinal tract.

Sakai H, Sawamura M, Tamura J, Okamura S, Karasawa M, Murakami H, Omine M, Nakazato Y, Naruse T, Tsuchiya J. Sakai H, et al. Among authors: murakami h. J Med. 1991;22(3):195-9. J Med. 1991. PMID: 1770327

3

Multiple autoantibody production in a patient with splenic lymphoma.

Sawamura M, Yamaguchi S, Murakami H, Amagai H, Matsushima T, Tamura J, Naruse T, Tsuchiya J. Sawamura M, et al. Among authors: murakami h. Ann Hematol. 1994 May;68(5):251-4. doi: 10.1007/BF01737426. Ann Hematol. 1994. PMID: 8018767

4

Ultrastructure of plasma cells in a patient with J chain disease.

Sawamura M, Kurabayashi H, Murakami H, Sakura T, Tamura J, Kubota K, Naruse T, Tsuchiya J. Sawamura M, et al. Among authors: murakami h. Am J Hematol. 1993 May;43(1):63-5. doi: 10.1002/ajh.2830430116. Am J Hematol. 1993. PMID: 8317467

5

Change of paraprotein from IgG lambda to lambda chain in myeloma.

Sawamura M, Murayama K, Tokizawa S, Matsushima T, Tamura J, Murakami H, Naruse T, Tsuchiya J. Sawamura M, et al. Among authors: murakami h. Ann Hematol. 1993 Apr;66(4):215-6. doi: 10.1007/BF01703239. Ann Hematol. 1993. PMID: 8485210

6

MCNU in the treatment of essential thrombocythemia--a pilot study.

Murakami H, Tamura J, Sawamura M. Murakami H, et al. Ann Hematol. 1993 May;66(5):247-9. doi: 10.1007/BF01738474. Ann Hematol. 1993. PMID: 8507720

7

Prognostic value of morphological classifications and clinical variables in elderly and young patients with multiple myeloma.

Kurabayashi H, Kubota K, Tsuchiya J, Murakami H, Tamura J, Naruse T. Kurabayashi H, et al. Among authors: murakami h. Ann Hematol. 1999 Jan;78(1):19-23. doi: 10.1007/s002770050466. Ann Hematol. 1999. PMID: 10037264

8

Risk factors for early death in patients undergoing treatment for multiple myeloma.

Murakami H, Hayashi K, Hatsumi N, Saitoh T, Yokohama A, Matsushima T, Tsukamoto N, Morita K, Karasawa M, Ogawara H, Sawamura M, Nojima Y. Murakami H, et al. Ann Hematol. 2001 Aug;80(8):452-5. doi: 10.1007/s002770100330. Ann Hematol. 2001. PMID: 11563589

9

Prognostic relevance of morphological classification in multiple myeloma.

Murakami H, Nemoto K, Sawamura M, Tamura J, Matsushima T, Naruse T, Tsuchiya J, Sato S, Shiamano S, Shinonome S, et al. Murakami H, et al. Acta Haematol. 1992;87(3):113-7. doi: 10.1159/000204735. Acta Haematol. 1992. PMID: 1642091

10

Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.

Ueki K, Sato S, Tamura J, Sawamura M, Murakami H, Naruse T, Tsuchiya J. Ueki K, et al. Among authors: murakami h. J Med. 1991;22(3):157-61. J Med. 1991. PMID: 1770323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,292 results

Search Page

Filters